Rating History for Galmed Pharmaceuticals (GLMD) by Canaccord
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/8/2022 | Edward Nash | Downgrade | Hold (Buy) |
1.00 (5.00) |
0.44 (0.68) |
54.55% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/8/2022 | Edward Nash | Downgrade | Hold (Buy) |
1.00 (5.00) |
0.44 (0.68) |
54.55% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||